1 terminated, 1 withdrawn. 2 Early Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Early Phase 1 | 2 | Terminated 1, Withdrawn 1 |
Follow Morphea: new trials by email Literature Review of Morphea trials Research Report on Morphea
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Hyaluronidase in Treating Oral Microstomia in Patients With Sclerosing Skin Disease hyaluronidase injected intradermally - Microstomia, Scleroderma | Early Phase 1 | Withdrawn | Brigham and Women's Hospital | 2020-01-01 | 2021-01-14 | |
| Molecular Effects of Topical Calcipotriene on Morphea topical calcipotriene 0.005% ointment - Morphea, Localized Scleroderma | Early Phase 1 | Terminated | Northwestern University | 2 | 2015-03-01 | 2018-09-13 |
Scleroderma, Localized (2) · CREST Syndrome (1) · Microstomia (1) · Scleroderma, Diffuse (1) · Scleromyxedema (1)
Connective Tissue Diseases (2) · Skin Diseases (2) · Skin and Connective Tissue Diseases (2) · Calcinosis (1) · Calcium Metabolism Disorders (1) · Cardiovascular Diseases (1) · Congenital Abnormalities (1) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Deglutition Disorders (1) · Digestive System Diseases (1) · Embolism and Thrombosis (1) · Esophageal Diseases (1) · Esophageal Motility Disorders (1) · Gastrointestinal Diseases (1) · Livedoid Vasculopathy (1)
Ointments (1) · calcipotriene (1)
Brigham and Women's Hospital (1) · Northwestern University (1)
United States (1)